Key statistics
On Wednesday, Sichuan Kelun-Biotech Biopharmaceutical Co Ltd (6990:HKG) closed at 167.10, -25.34% below its 52-week high of 223.80, set on Oct 04, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 173.10 |
---|---|
High | 173.80 |
Low | 165.00 |
Bid | 167.10 |
Offer | 167.70 |
Previous close | 175.00 |
Average volume | 300.35k |
---|---|
Shares outstanding | 222.84m |
Free float | 134.28m |
P/E (TTM) | -- |
Market cap | 39.00bn HKD |
EPS (TTM) | -1.11 HKD |
Data delayed at least 15 minutes, as of Nov 13 2024 08:08 GMT.
More ▼
- Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) Third NDA Accepted by NMPA, locally advanced or metastatic EGFR-mutant NSCLC
- Multiple Study Results of Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) at 2024 CSCO Congress
- Three Study Results Abstracts From Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) At 2024 ESMO Released Today
- Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) Second NDA Accepted by NPMA, locally advanced or metastatic EGFR-mutant NSCLC